Navigation Links
PharmD in Medical News

Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy

SWARTZ CREEK, Mich., June 2 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced the promotion of Dr. Rinku A. Patel to Vice President, Pharmacy Strategy. Patel was previously Diplomat's Director of Pharmacy Development and Operations. Patel's new role will encompass 3 main areas: ...

Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring

...encourage sufferers who have questions about nasal congestion products or how to access these products to ask their pharmacist," said Michael Negrete, pharmd of the American Pharmacists Association. "Many people are unaware that some of the oral decongestant medicines they have relied on for years are still...

Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy

...s clinical pharmacists, Patrick Gleason, PharmD, FCCP, BCPS, Cathy Starner, pharmd and Jeremy Schafer, pharmd were awarded the Journal of Managed Care Pharmacy (JMCP) Award of Excellenc...

Clearing the 'fog'

...kill the tumor, not if they cause a cognitive deficiency, like memory loss." Walker and Raffa decided to fill that void. Two years ago, Walker and pharmd student John Foley, set out to see if certain chemotherapeutic agents caused memory and learning deficits in mice. They tested two older drugs commonl...

CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

...ragen.com . CRGN-G Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports First Quarter 2008 Financial Results

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDENSE...

Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine

...after 6 months. This study adds to the current literature on the economic value of comprehensive pain programs. Investigators: Julie L. Cunningham, pharmd Mayo Clinic, Rochester, MN 55902 Jeffrey D. Rome Mayo Clinic, Rochester, MN 55905 Cynthia O. Townsend Mayo Clinic, Rochester, MN 55905 Jennifer L. Ker...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C

...e fundamental basis for the impaired responsiveness in this population, they say. In an accompanying editorial, Steven-Huy Han, MD and Jason Smith, pharmd of Los Angeles, report that this study adds significantly to our understanding of interferon therapy in African American patients. It will change the ...
PharmD in Medical Technology

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

... on Addictions, University at Buffalo , Buffalo, NY Isabel Burk, MS Director of The Health Network, New York, NY Jeanna M. Marraffa, pharmd Clinical Toxicologist, Upstate New York Poison Center, Assistant Professor, SUNY Upstate Medical University , Syracuse, NY Phil Buckenmeyer,...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... otherwise. CRGN-P Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008

...ragen.com . CRGN-F Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com (203) 871-4400 Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...rmation, future events or otherwise. Contacts: Sean Cassidy Vice President and Chief Financial Officer scassidy@curagen.com Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-F - FINANCIAL TABLES ATTACHED - ...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

...e or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

...s release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen Advances CR011-vcMMAE into Phase II

...ss release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 CRGN-P ...

CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference

...ress release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-P ...
PharmD in Biological Technology

Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance

PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring th...

Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and developmen...

L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD

Scott Karasinski, PharmD to Run Medical Services Department of the Expanding Independent Medical Education Agency MOUNTAINSIDE, N.J., Feb. 5 /PRNewswire/ -- L&M Healthcare Communications announces the appointment of Scott Karasinski, PharmD to the position of Vice President, Sci...

EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD

OAK BROOK, Ill., Nov. 5 /PRNewswire/ -- EPI-Q, Inc., a consulting firm providing outcomes research and health economics services to the global biopharmaceutical and healthcare industries, announces the addition of Anthony J. Vita, MD, MPH and Peter Herout, PharmD to their team of clinical prof...

CuraGen Sells Ownership of Belinostat to TopoTarget A/S

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-P Contacts: Glenn Schulman, pharmd Director of Medical Communications gschulman@curagen.com (888) 436-6642 ...

Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis

...me required for follow-up monitoring in a costly critical care unit compared with CDT patients. The study, which was authored by Daniel E. Hilleman, pharmd (Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE) and Mahmood K. Razavi, MD (Department of Vascular and Interventi...

CuraGen to Present at the BIO CEO & Investor Conference

...orporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com . Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CRGN-G ...

CuraGen Reports Fourth Quarter and Year End 2007 Financial Results

... release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 CURAGEN CORPORATION AND SUBSIDIARY CONDE...

CuraGen Corporation Receives Notification from NASDAQ

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-F Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...

CuraGen Corporation Announces Appointment of Sean Cassidy as CFO

... or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CRGN-G Contacts: Glenn Schulman, pharmd Director of Investor Relations gschulman@curagen.com (888) 436-6642 ...
Other Tags
(Date:7/2/2015)... ... July 02, 2015 , ... ... consulting services to the federal government, has announced they are among nine contractors ... Management Office Support Services (BMOSS) contract not to exceed $250 million. , ...
(Date:7/2/2015)... ... , ... Hand sanitizers have become extremely popular with an annual industry growth ... advocate and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of ... sanitizers must be applied correctly and users must be aware of its limitations. ...
(Date:7/2/2015)... ... ... Throughout the month of April, Casey’s General Stores invited customers to give ... 7, Casey’s General Stores Chairman and CEO, Bob Myers, will present a check to ... nonprofit dedicated to restoring a sense of self, restoring the family unit, and restoring ...
(Date:7/2/2015)... ... July 02, 2015 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it has made two key appointments at ... General Manager at Catalent’s Schorndorf facility, which provides large scale, complex oral solid ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... A team ... manager, have adopted Lean methodology in their QC laboratory for enhanced workflow. Now, Dr. ... Six Sigma Laboratory within the GE Healthcare Diagnostic Imaging network. , Join ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, a ... authentication solutions, today announced enhanced functionality of its ... solution.  The enhancements build on the native ... DigitalPersona Altus platform and provide expanded mobile ... In today,s environment of increasing cyber-attacks ...
(Date:6/17/2015)... , June 17, 2015  Synaptics Inc. ... interface solutions, today announced that Xiaomi, one of ... Synaptics ® ClearPad ® family of ... driver integrated circuits (DDICs) for its latest smartphones, ... leveraging ClearPad for full in-cell display solutions and ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
Other Contents